Ashraf Amanullah

Merck & Co., Inc., Rahway, NJ, USA (United States)

Papers

1

Total Citations

110

H-Index

1

About

Dr. Ashraf Amanullah is a leading authority in bioprocess engineering, with a primary focus on the development of high-throughput technologies for cell culture process development. His most cited work, a seminal 2010 paper with over 110 citations, addresses a critical bottleneck in the biopharmaceutical industry: the need for rapid, scalable, and resource-efficient methods to develop robust fed-batch processes for therapeutic protein production. Dr. Amanullah’s major contribution lies in the validation of novel micro-bioreactor systems, demonstrating their reproducibility and scalability against traditional bench-top bioreactors. This breakthrough enables researchers to conduct a far greater number of parallel experiments, dramatically expanding the design space for process optimization while reducing timelines and material costs. By providing a reliable platform for high-throughput screening, his work has accelerated the development of manufacturing processes for critical therapeutic and vaccine candidates. Dr. Amanullah’s research is instrumental in bridging the gap between early-stage discovery and commercial-scale production, making him a pivotal figure in modern bioprocessing.

Research Focus

Key Achievements

1
H-Index
1
Papers
110
Total Citations
110
Avg Citations/Paper
🏆 Most Cited Paper
Novel micro‐bioreactor high throughput technology for cell culture process development: Reproducibility and scalability assessment of fed‐batch CHO cultures
110 citations · 2010
📈 Most Prolific Year: 2010 (1 Papers)
🤝 Key Collaborators: 8
🏛 Institutions: Merck & Co., Inc., Rahway, NJ, USA (United States)

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 12 days ago